<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>About & Download - FDA COVID-19 Vaccine Manufacturing Questions</title>
    <meta name="description" content="About the 248 scientific questions regarding COVID-19 vaccine manufacturing, safety testing, and regulatory oversight">

    <!-- Open Graph / Facebook -->
    <meta property="og:type" content="website">
    <meta property="og:url" content="https://248questions.org/about.html">
    <meta property="og:title" content="About the 248 Scientific Questions for FDA">
    <meta property="og:description" content="About the scientific inquiry into COVID-19 vaccine manufacturing, safety testing, and regulatory oversight">
    <meta property="og:image" content="https://248questions.org/images/og-image.png">

    <!-- Twitter -->
    <meta property="twitter:card" content="summary_large_image">
    <meta property="twitter:url" content="https://248questions.org/about.html">
    <meta property="twitter:title" content="About the 248 Scientific Questions for FDA">
    <meta property="twitter:description" content="About the scientific inquiry into COVID-19 vaccine manufacturing, safety testing, and regulatory oversight">
    <meta property="twitter:image" content="https://248questions.org/images/og-image.png">

    <link rel="stylesheet" href="style.css">
    <style>
        .two-column-layout {
            display: flex;
            gap: 3rem;
            margin-top: 2rem;
        }
        .column-left, .column-right {
            flex: 1;
        }
        .column-left ul, .column-right ul {
            margin-left: 1.5rem;
        }
        .download-card {
            background: white;
            padding: 2rem;
            border-radius: 8px;
            box-shadow: 0 2px 8px rgba(0,0,0,0.1);
            margin-bottom: 2rem;
        }
        .download-btn {
            display: inline-block;
            padding: 12px 30px;
            background: #3498db;
            color: white;
            text-decoration: none;
            border-radius: 5px;
            font-size: 1.1rem;
            transition: background 0.3s;
            margin-top: 1rem;
        }
        .download-btn:hover {
            background: #2980b9;
        }
        .citation-box {
            background: #f8f9fa;
            padding: 1rem;
            border-left: 4px solid #3498db;
            margin: 1rem 0;
        }
        .paper-title {
            font-style: italic;
            color: #555;
            margin: 1rem 0;
        }
        @media (max-width: 768px) {
            .two-column-layout {
                flex-direction: column;
            }
        }
    </style>
</head>
<body>
    <header>
        <h1>Scientific Questions on COVID-19 Vaccines</h1>
        <p class="subtitle">248 Questions for FDA on Manufacturing, Safety Testing, and Regulatory Oversight</p>
        <nav>
            <a href="index.html">Home</a>
            <a href="split-screen.html">Split Screen</a>
            <a href="glossary.html">Glossary</a>
            <a href="about.html" class="active">About</a>
            <a href="support.html">Support</a>
        </nav>
    </header>

    <main>
        <div class="two-column-layout">
            <!-- Left Column: Download Content -->
            <div class="column-left">
                <h2>Download Full Document</h2>
                <div class="download-card">
                    <h3>Complete Testimony</h3>
                    <p class="paper-title">"Great expectations and generous reading of guidelines underestimate potential risk in oversight of COVID-19 pro-vaccine quality, safety testing and manufacturing: 248 questions for FDA"</p>

                    <p><strong>Authors:</strong> David Wiseman, PhD, MRPharmS and Maria Gutschi, BScPhm, PharmD</p>

                    <ul>
                        <li>248 detailed scientific questions</li>
                        <li>Published on ResearchGate</li>
                    </ul>

                    <a href="https://www.researchgate.net/publication/395467231_Great_expectations_and_generous_reading_of_guidelines_underestimate_potential_risk_in_oversight_of_COVID-_19_pro-vaccine_quality_safety_testing_and_manufacturing_248_questions_for_FDA"
                       class="download-btn primary"
                       target="_blank"
                       rel="noopener noreferrer">
                        View on ResearchGate
                    </a>
                </div>

                <h3>How to Cite</h3>
                <div class="citation-box">
                    <p>Wiseman, D., & Gutschi, L. M. (2025). Great expectations and generous reading of guidelines underestimate potential risk in oversight of COVID-19 pro-vaccine quality, safety testing and manufacturing: 248 questions for FDA. ResearchGate. DOI: 10.13140/RG.2.2.36082.73929</p>
                </div>
            </div>

            <!-- Right Column: About Content -->
            <div class="column-right">
                <h2>About This Project</h2>
                <p>This document presents 248 questions to the FDA regarding COVID-19 mRNA vaccine manufacturing processes, safety testing, and regulatory oversight. The questions arise from analysis of regulatory documents, FOIA disclosures, and peer-reviewed research.</p>

                <h3>Key Areas of Inquiry</h3>
                <ul>
                    <li>Manufacturing process changes between clinical trials and commercial production</li>
                    <li>Residual DNA contamination and SV40 sequence elements</li>
                    <li>Adequacy of genotoxicity and biodistribution studies</li>
                    <li>Discovery of frameshift proteins</li>
                    <li>Regulatory compliance and disclosure</li>
                </ul>

                <h3>Purpose</h3>
                <p>The purpose of this compilation is to:</p>
                <ul>
                    <li>Promote transparency in vaccine manufacturing and regulation</li>
                    <li>Ensure comprehensive safety testing and quality control</li>
                    <li>Address scientific concerns raised by researchers and healthcare professionals</li>
                    <li>Support informed decision-making by regulatory authorities</li>
                    <li>Contribute to the scientific discourse on vaccine safety and efficacy</li>
                </ul>

                <h3>Question Categories</h3>
                <p>The 248 questions are organized into seven main categories:</p>
                <ul>
                    <li><strong>Manufacturing Process:</strong> Changes between trials and production</li>
                    <li><strong>DNA Contamination:</strong> Residual DNA levels and contamination</li>
                    <li><strong>Safety Studies:</strong> Comprehensiveness of safety testing</li>
                    <li><strong>Regulatory Compliance:</strong> Process compliance with guidelines</li>
                    <li><strong>Genotoxicity:</strong> Potential genetic toxicity</li>
                    <li><strong>Biodistribution:</strong> Vaccine distribution in the body</li>
                    <li><strong>Frameshift Proteins:</strong> Discovery and implications</li>
                </ul>
            </div>
        </div>

        <section id="disclaimer" style="margin-top: 3rem; padding: 1.5rem; background: #f8f9fa; border-radius: 8px;">
            <h3>Important Note</h3>
            <p>This website presents scientific questions and analysis for academic and research purposes. It is not intended as medical advice. Healthcare decisions should be made in consultation with qualified medical professionals.</p>
        </section>
    </main>

    <footer>
        <p>&copy; 2025 David Wiseman, PhD, MRPharmS & Maria Gutschi, BScPhm, PharmD</p>
        <p class="disclaimer">This website presents scientific questions and analysis. It is not medical advice.</p>
    </footer>

    <script src="common.js"></script>
</body>
</html>
